Silexion Therapeutics Corp (NASDAQ:SLXN) does about 10.85M shares in volume on a normal day but saw 9131193 shares change hands in the recent trading day. The company now has a market cap of 7.59M USD. Its current market price is $1.90, marking a decrease of -7.32% compared to the previous close of $2.05. The 52 week high reached by this stock is $122.02 whilst the lowest price level in 52 weeks is $0.57.
Silexion Therapeutics Corp (SLXN) has a 20-day trading average at $1.5617 and the current price is -98.44% off the 52-week high compared with 230.43% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.2428. If we look at the stock’s price movements over the week, volatility stands at 41.17%, which decreases to 21.59% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 51.16 to suggest the stock is neutral.
The consensus objective for the share price is $9.00, suggesting that the stock has a potential upside of 78.89% over the period.
The current price level is 21.67%, -15.28%, and -95.82% away from its SMA20, SMA50, and SMA200 respectively, with the SLXN price moving above the 50-day SMA on current market day. Silexion Therapeutics Corp (SLXN) stock is up 186.36% over the week and -16.30% over the past month. Its price is -5.47% year-to-date and -97.93% over the past year.
To reach the target analysts have set, the stock logically needs to grow 78.89 percent from here.
Outstanding shares total 4.00M with insiders holding 32.57% of the shares and institutional holders owning 8.15% of the company’s common stock. The company has a return on equity of -3.78%. The beta has a value of 0.04.
